Educational Activity

Page 2

Posts about this type

JCP
Impact of Dementia-Related Psychosis
DELETE eReport

November 3, 2020

When you treat patients with dementia-related psychosis, do you evaluate the burden on carers, too? If they feel discomfort, fear, or depression, how would you help them? Learn from...
Dag Aarsland
JCP
DELETE eReport

October 27, 2020

Do you talk with your patients with Parkinson disease about the burden of OFF episodes? Using assessment tools can spur communication. In this CME activity, follow along as 2...
Rajesh Pahwa, Stuart H. Isaacson
JCP
DELETE eReport

September 29, 2020

Read an article on how to reduce Tardive dyskinesia (TD) symptoms, including the use of the FDA-approved treatment options (valbenazine and deutetrabenazine).
Joseph P. McEvoy
JCP
DELETE eReport

September 15, 2020

Learn from experts about recognizing symptoms and managing dementia-related psychosis (DRP) with engaging CME activities.
Dag Aarsland
JCP
DELETE eReport

September 8, 2020

Individuals with narcolepsy may experience not only academic, social, and occupational consequences but also dangerous driving or other accidents, meaning that effective treatment is critical. Here, review the evidence...
Thomas Roth
JCP
DELETE eReport

July 21, 2020

Read an article on how to diagnose narcolepsy and which patients need evaluation for excessive daytime sleepiness and central hypersomnias.
John W. Winkelman
JCP
Overcoming Challenges to Treat Inadequate Response in MDD
DELETE eReport

May 12, 2020

How do you determine if a patient is experiencing nonresponse to an antidepressant? In this activity, experts discuss augmentation and adjunctive treatment strategies, as well as best practices for...
George I. Papakostas, W. Clay Jackson, Roueen Rafeyan, et al
JCP
Educational Activity

May 12, 2020

You can help your patients with schizophrenia achieve the ultimate goal of treatment—recovery. Learn how to use patient-centered care to enhance medication adherence and aid functional recovery.
John Lauriello
JCP
Augmentation and Adjunctive Strategies for Inadequate Response in MDD
DELETE eReport

May 12, 2020

When a patient with major depressive disorder isn't responding to antidepressant treatment, what are your next moves? In this activity, learn from the experts about augmentation and adjunctive strategies.
Roueen Rafeyan, George I. Papakostas, W. Clay Jackson, et al
JCP
Recognizing Inadequate Response in Patients With MDD
DELETE eReport

May 5, 2020

Can you recognize inadequate antidepressant response? How does it differ from treatment-resistant depression? In this activity, experts discuss definitions of response as well as residual symptoms seen with inadequate...
W. Clay Jackson, George I. Papakostas, Roueen Rafeyan, et al
JCP
Use of Measurement-Based Care to Address Inadequate Antidepressant Response
DELETE eReport

May 5, 2020

You may think using rating scales to measure depression symptoms takes too long. But that time may be well spent. In this activity, experts discuss the value of measurement-based...
Madhukar H. Trivedi, George I. Papakostas, W. Clay Jackson, et al
JCP
Educational Activity

April 21, 2020

For people living with Alzheimer's disease, sleep disturbances are often problematic for the patient and their family. In this CME webcast, watch short videos to gain insight from experts...
Alon Avidan, Anna Burke
JCP
Educational Activity

April 14, 2020

Patient-reported outcomes are important for assessing the impact of schizophrenia and the success of treatment. Dr Correll discusses patient-centered care.
Christoph U. Correll
JCP
Educational Activity

April 14, 2020

New treatments for schizophrenia may improve symptom domains other than positive symptoms and reduce adverse effects. Here, an expert summarizes data on approved and investigational agents.
Christoph U. Correll
JCP
Educational Activity

March 24, 2020

What can you do to combat relapse in your patients with schizophrenia? Dr Lauriello discusses identifying and addressing a major contributor to relapse—nonadherence to antipsychotics.
John Lauriello
JCP
Educational Activity

March 17, 2020

When you are treating a patient for depression, do you regularly assess symptoms, adherence, and side effects using tools and then use that information to guide treatment decisions? Learn...
Madhukar H. Trivedi
JCP
Educational Activity

March 17, 2020

Identification of depression is crucial, as untreated depression is linked to functional impairment and suicide. Learn from an expert about how measurement-based care provides a way to improve the...
Madhukar H. Trivedi
JCP
Educational Activity

January 28, 2020

After so many years of having inadequate treatment options, you can finally offer patients with tardive dyskinesia approved medications that reduce symptoms. Follow along as expert Dr Leslie Citrome...
Leslie L. Citrome
JCP
Educational Activity

January 14, 2020

Tardive dyskinesia must be detected early to minimize the risk of permanence. Do you know how often to screen patients and how to conduct an evaluation? Dr Stephen Saklad...
Stephen R. Saklad
JCP
Educational Activity

January 7, 2020

Which medications can improve the various motor and nonmotor symptoms of Parkinson disease? Dr Isaacson offers strategies to address multiple challenges posed by the illness.
Stuart H. Isaacson
JCP
Educational Activity

January 7, 2020

Guidelines lay out strategies for maintenance treatment of bipolar I disorder, with an algorithm for pharmacologic and psychosocial interventions. Dr Suppes describes guideline recommendations and situations when you might...
Trisha Suppes
JCP
Educational Activity

December 31, 2019

When should you rely on top-ranked treatment options for acute bipolar mania, and when should you skip down to lower-ranked options? In this brief CME activity, expert Dr Suppes...
Trisha Suppes
JCP
Educational Activity

December 31, 2019

What are the cardinal features of Parkinson disease? What other motor and nonmotor symptoms do patients experience? Dr Isaacson describes diagnostic criteria and assessment tools.
Stuart H. Isaacson
JCP
Educational Activity

December 24, 2019

What steps do you take when patients exhibit tardive dyskinesia? Are you familiar with treatment guidelines and data on approved and non-approved strategies? Explore recommendations from Dr Daniel Kremens.
Daniel E. Kremens

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe